Critical Outcome Technologies Inc. (COTI) (TSX VENTURE:COT) today announced positive results from the first phase of its HIV integrase inhibitor discovery program. These results provide novel intellectual property to the Company and further validation of the CHEMSAS® drug discovery technology...